Pages that link to "Q37978963"
Jump to navigation
Jump to search
The following pages link to Blocking seizures with the diuretic bumetanide: promises and pitfalls. (Q37978963):
Displaying 11 items.
- Neonatal Seizures: Impact on Neurodevelopmental Outcomes (Q26774470) (← links)
- Educational paper: do we need neonatal clinical pharmacologists? (Q27009662) (← links)
- Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters (Q30650230) (← links)
- Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus. (Q33620044) (← links)
- Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter (Q36036218) (← links)
- The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A. (Q39843309) (← links)
- The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice (Q39964341) (← links)
- Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy (Q44616602) (← links)
- A novel prodrug-based strategy to increase effects of bumetanide in epilepsy (Q46921173) (← links)
- A resurging boom in new drugs for epilepsy and brain disorders. (Q48093388) (← links)
- The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero (Q83228811) (← links)